XML 40 R31.htm IDEA: XBRL DOCUMENT
v3.22.2

Earnings Per Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Earnings Per Share [Abstract] |
Computation of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2022 and 2021 (in thousands, except per share amounts):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 80,079 |  |  | $ | 44,514 |  |  | $ | 140,916 |  |  | $ | 66,872 |
Loss from discontinued operations |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (12,641 | )
Net income attributable to Acadia Healthcare Company, Inc. |  | $ | 80,079 |  |  | $ | 44,514 |  |  | $ | 140,916 |  |  | $ | 54,231 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average shares outstanding for basic earnings per share |  |  | 89,724 |  |  |  | 88,842 |  |  |  | 89,492 |  |  |  | 88,543 |
Effects of dilutive instruments |  |  | 1,749 |  |  |  | 1,748 |  |  |  | 2,012 |  |  |  | 1,838 |
Shares used in computing diluted earnings per common share |  |  | 91,473 |  |  |  | 90,590 |  |  |  | 91,504 |  |  |  | 90,381 |
Basic earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.89 |  |  | $ | 0.50 |  |  | $ | 1.57 |  |  | $ | 0.76 |
Loss from discontinued operations |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (0.15 | )
Net income attributable to Acadia Healthcare Company, Inc. |  | $ | 0.89 |  |  | $ | 0.50 |  |  | $ | 1.57 |  |  | $ | 0.61 |
Diluted earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.88 |  |  | $ | 0.49 |  |  | $ | 1.54 |  |  | $ | 0.74 |
Loss from discontinued operations |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (0.14 | )
Net income attributable to Acadia Healthcare Company, Inc. |  | $ | 0.88 |  |  | $ | 0.49 |  |  | $ | 1.54 |  |  | $ | 0.60 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration